2-(4-propan-2-ylsulfonylphenyl)-N-(pyridin-4-ylmethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide
C22H21N5O3S — CID 71208109
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-propan-2-ylsulfonylphenyl)-N-(pyridin-4-ylmethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide
2-(4-propan-2-ylsulfonylphenyl)-N-(pyridin-4-ylmethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide (PubChem CID 71208109) has the molecular formula C22H21N5O3S and a molecular weight of 435.51 g/mol. Its IUPAC name is 2-(4-propan-2-ylsulfonylphenyl)-N-(pyridin-4-ylmethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide.
Molecular Properties
| Compound Name | 2-(4-propan-2-ylsulfonylphenyl)-N-(pyridin-4-ylmethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide |
|---|---|
| PubChem CID | 71208109 |
| Molecular Formula | C22H21N5O3S |
| Molecular Weight | 435.51 g/mol |
| Exact Mass | 435.14 |
| IUPAC Name | 2-(4-propan-2-ylsulfonylphenyl)-N-(pyridin-4-ylmethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide |
| SMILES | CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)NCc4ccncc4)c3n2)cc1 |
| InChI | InChI=1S/C22H21N5O3S/c1-14(2)31(29,30)17-5-3-16(4-6-17)19-13-25-21-20(27-19)18(12-24-21)22(28)26-11-15-7-9-23-10-8-15/h3-10,12-14H,11H2,1-2H3,(H,24,25)(H,26,28) |
| InChIKey | DMJCUEHIYMKGPJ-UHFFFAOYSA-N |
| XLogP | 3.13 |
| TPSA | 117.70 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.51 |
| LogP ≤ 5 | 3.13 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71208109 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.